Plan debates typically return to scheduling and bans. India and the United States both of those experience versions of the exact same issue: regardless of whether to impose broader, class-huge controls above fentanyl analogs as well as their precursors, or to keep material-by-compound scheduling that will lag at the rear of traffickers’ innovatio